{"denomUnitsSelected":"Participants","description":"The FACT/GOG-Ntx is a patient-reported outcome measure used to assess health-related quality of life in patients undergoing cancer therapy, plus an eleven-item subscale (Ntx subscale) that evaluates symptoms and concerns associated specifically with chemotherapy-induced neuropathy.","reportingStatus":"NOT_POSTED","timeFrame":"Baseline to 16 weeks post-last-dose of study treatment (Dara, R, V or d)","title":"Neurotoxicity Assessment Changes From Baseline Using Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx) Questionnaire.","type":"SECONDARY"}